ALSENLITE: Senolytics for Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is being done to evaluate the safety and feasibility of using Dasatinib and Quercetin together in subjects with Mild Cognitive Impairment (MCI) or Alzheimer\'s disease.
Epistemonikos ID: cedce4792ae38f1902f5c712601af47d4964948d
First added on: May 08, 2024